81 research outputs found
Glycosylation Tunes Neuroserpin Physiological and Pathological Properties
Neuroserpin (NS) is a member of the serine protease inhibitors superfamily. Specific point
mutations are responsible for its accumulation in the endoplasmic reticulum of neurons that leads to
a pathological condition named familial encephalopathy with neuroserpin inclusion bodies (FENIB).
Wild-type NS presents two N-glycosylation chains and does not form polymers in vivo, while
non-glycosylated NS causes aberrant polymer accumulation in cell models. To date, all in vitro
studies have been conducted on bacterially expressed NS, de facto neglecting the role of glycosylation
in the biochemical properties of NS. Here, we report the expression and purification of human
glycosylated NS (gNS) using a novel eukaryotic expression system, LEXSY. Our results confirm the
correct N-glycosylation of wild-type gNS. The fold and stability of gNS are not altered compared
to bacterially expressed NS, as demonstrated by the circular dichroism and intrinsic tryptophan
fluorescence assays. Intriguingly, gNS displays a remarkably reduced polymerisation propensity
compared to non-glycosylated NS, in keeping with what was previously observed for wild-type NS
in vivo and in cell models. Thus, our results support the relevance of gNS as a new in vitro tool to
study the molecular bases of FENIB
Glycosylation tunes neuroserpin physiological and pathological properties
Neuroserpin (NS) is a member of the serine protease inhibitors superfamily. Specific point
mutations are responsible for its accumulation in the endoplasmic reticulum of neurons that leads to
a pathological condition named familial encephalopathy with neuroserpin inclusion bodies (FENIB).
Wild-type NS presents two N-glycosylation chains and does not form polymers in vivo, while
non-glycosylated NS causes aberrant polymer accumulation in cell models. To date, all in vitro
studies have been conducted on bacterially expressed NS, de facto neglecting the role of glycosylation
in the biochemical properties of NS. Here, we report the expression and purification of human
glycosylated NS (gNS) using a novel eukaryotic expression system, LEXSY. Our results confirm the
correct N-glycosylation of wild-type gNS. The fold and stability of gNS are not altered compared
to bacterially expressed NS, as demonstrated by the circular dichroism and intrinsic tryptophan
fluorescence assays. Intriguingly, gNS displays a remarkably reduced polymerisation propensity
compared to non-glycosylated NS, in keeping with what was previously observed for wild-type NS
in vivo and in cell models. Thus, our results support the relevance of gNS as a new in vitro tool to
study the molecular bases of FENIB
The elusive nature and diagnostics of misfolded Aβ oligomers.
Amyloid-beta (Aβ) peptide oligomers are believed to be the causative agents of Alzheimer's disease (AD). Though post-mortem examination shows that insoluble fibrils are deposited in the brains of AD patients in the form of intracellular (tangles) and extracellular (plaques) deposits, it has been observed that cognitive impairment is linked to synaptic dysfunction in the stages of the illness well before the appearance of these mature deposits. Increasing evidence suggests that the most toxic forms of Aβ are soluble low-oligomer ligands whose amounts better correlate with the extent of cognitive loss in patients than the amounts of fibrillar insoluble forms. Therefore, these ligands hold the key to a better understanding of AD prompting the search for clearer correlations between their structure and toxicity. The importance of such correlations and their diagnostic value for the early diagnosis of AD is discussed here with a particular emphasis on the transient nature and structural plasticity of misfolded Aβ oligomers
The kinetic dose limit in room-temperature time-resolved macromolecular crystallography
The effect of the X-ray dose on room-temperature time-resolved Laue data is discussed
The 4C5 Cell-Impermeable Anti-HSP90 Antibody with Anti-Cancer Activity, Is Composed of a Single Light Chain Dimer
MAb 4C5 is a cell impermeable, anti-HSP90 murine monoclonal antibody, originally produced using hybridoma technology. We have previously shown that mAb 4C5 specifically recognizes both the α- and to a lesser extent the β-isoform of HSP90. Additionally, in vitro and in vivo studies revealed that by selectively inhibiting the function of cell-surface HSP90, mAb 4C5 significantly impairs cancer cell invasion and metastasis. Here we describe the reconstitution of mAb 4C5 into a mouse-human chimera. More importantly we report that mAb 4C5 and consequently its chimeric counterpart are completely devoid of heavy chain and consist only of a functional kappa light chain dimer. The chimeric antibody is shown to retain the original antibody's specificity and functional properties. Thus it is capable of inhibiting the function of surface HSP90, leading to reduced cancer cell invasion in vitro. Finally, we present in vivo evidence showing that the chimeric 4C5 significantly inhibits the metastatic deposit formation of MDA-MB-453 cells into the lungs of SCID mice. These data suggest that a chimeric kappa light chain antibody could be potentially used as an anti-cancer agent, thereby introducing a novel type of antibody fragment, with reduced possible adverse immunogenic effects, into cancer therapeutics
Radiation damage in macromolecular crystallography: what is it and why should we care?
The basic causes of the radiation damage inflicted on macromolecular crystals during diffraction experiments are summarized, as well as the current state of research which attempts to understand and to mitigate it
Temperature-dependent macromolecular X-ray crystallography
The dynamical behaviour of crystalline macromolecules and their surrounding solvent as a function of cryo-temperature is reviewed
Structural basis of L -phosphoserine binding to Bacillus alcalophilus phosphoserine aminotransferase
Phosphoserine aminotransferase is a vitamin B6-dependent enzyme that catalyzes the reversible conversion of 3-Âphosphohydroxypyruvate to L-phosphoserine using glutamate as an amine donor. In an effort to gain insight into the substrate-recognition mechanism of the enzyme, crystal structures of Bacillus alcalophilus phosphoserine aminotransferase in the presence or absence of L-phosphoserine were determined to resolutions of 1.5 and 1.6 Ã…, respectively. Local conformational changes induced upon substrate binding were identified. However, in contrast to other aminotransferases, no domain or subunit movements were observed. Two Arg residues (Arg42 and Arg328) and two His residues (His41 and His327) were found to form a tight binding site for the phosphate group of L-Âphosphoserine. Comparison with Escherichia coli phosphoserine aminotransferase in complex with the substrate analogue [alpha]-Âmethylglutamate revealed more extensive structural changes in the case of L-phosphoserine binding. Based on the structural analysis, the flexibility of Arg328 is proposed to be critical for substrate recognition
- …